Health UMass Chan launches new center with study of digital intervention for patients using GLP-1 medications November 12, 2025 11:06 am Pat Sargent 0 Min Read SHARE Enrollment in the study will start in early 2026, with a focus on patients recently initiating GLP-1 therapies in the Worcester area. This post was originally published on this site Previous Article Valley Lutheran, Reese win to set up volleyball regional showdown Next Article Small Changes, Big Impact: Lifestyle Modifications That Can Prevent Diabetes